Cooper Ronald Harold Wilfred

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 55% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cooper Ronald Harold Wilfred's trades of enGene Therapeutics Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
259.23
Quantity 17,657 +36.8%
Value US$39,809
Transaction date
Planned sale
Price
43.44
Quantity 42,981 -47.5%
Value US$4,847,489
Transaction date
Planned sale
Price
24.67
Quantity 929 -1.6%
Value US$22,923
Transaction date
Planned sale
Price
33.11
Quantity 907 -1.6%
Value US$30,031
Transaction date
Planned sale
Price
24.88
Quantity 3,684 -6.1%
Value US$91,666
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-01 2024-09-27
B Purchase
61,435 +48.3%
448.74
US$967,331 		61,435 +48.3% 448.74 US$967,331
2023-01-23 2023-01-23
PlS Planned sale
17,657 +36.8%
259.23
US$39,809 		17,657 +36.8% 259.23 US$39,809
2022-10-25 2022-10-24
PlS Planned sale
42,981 -47.5%
43.44
US$4,847,489 		42,981 -47.5% 43.44 US$4,847,489
2022-07-25 2022-07-22
PlS Planned sale
929 -1.6%
24.67
US$22,923 		929 -1.6% 24.67 US$22,923
2022-04-25 2022-04-22
PlS Planned sale
907 -1.6%
33.11
US$30,031 		907 -1.6% 33.11 US$30,031
2022-01-25 2022-01-24
PlS Planned sale
3,684 -6.1%
24.88
US$91,666 		3,684 -6.1% 24.88 US$91,666